Reinilde Heyrman Net Worth & Insider Trades

Reinilde Heyrman - Chief Clinical Dev. Officer, Bellerophon Therapeutics, Inc

As of March 16, 2015

What is Reinilde Heyrman's Net Worth?

The current estimated net worth of Bellerophon Therapeutics, Inc's Chief Clinical Dev. Officer, Reinilde Heyrman, is estimated to be about $8.86K . Reinilde Heyrman owns about 9,483 units of Bellerophon Therapeutics, Inc common stock. In the last month at Bellerophon Therapeutics, Inc, Reinilde Heyrman has sold an estimated value of $0 worth.

What is Reinilde Heyrman's Past Insider Trading?

Reinilde Heyrman's largest purchase order was 1,500 units , worth over $18K on February 23, 2015. In total, Reinilde Heyrman has made about 3 transactions over a month of their time at Bellerophon Therapeutics, Inc. Reinilde Heyrman usually trades in February, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Reinilde Heyrman's' Mailing Address?

  • Mailing address is Perryville Iii Corporate Park 53 Frontage Road, Suite 301 Hampton NJ 08827 NJ

What are Bellerophon Therapeutics, Inc's Past Insider Trades?

Bellerophon Therapeutics, Inc's most recent insider trade came on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky who sold 400,000 units worth $2.19M . In the last 6 years, insiders at Bellerophon Therapeutics, Inc have sold an estimated value of $3.99M and bought an estimated value of $74.83M worth of shares. Insider trading is most common in September, with the busiest year in 2018. The most active traders at the company are Jonathan M Peacock,  Theodore T Wang,  and Peter Fernandes, CHIEF REGULATORY & SAFETY OFFR .

Bellerophon Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1